{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:23:10Z","timestamp":1790745790187,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018779","name":"Milner Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Secondary bacterial infections are a potentially fatal complication of influenza infection. We aimed to define the impact of secondary bacterial infections on the clinical course and mortality in coronavirus disease 2019 (COVID-19) patients by comparison with influenza patients. COVID-19 (n\u2009=\u2009642) and influenza (n\u2009=\u2009742) patients, admitted to a large tertiary center in Israel and for whom blood or sputum culture had been taken were selected for this study. Bacterial culture results, clinical parameters, and death rates were compared. COVID-19 patients had higher rates of bacterial infections than influenza patients (12.6% vs. 8.7%). Notably, the time from admission to bacterial growth was longer in COVID-19 compared to influenza patients (4 (1\u20138) vs. 1 (1\u20133) days). Late infections (&gt;\u200948\u00a0h after admission) with gram-positive bacteria were more common in COVID-19 patients (28% vs. 9.5%). Secondary infection was associated with a higher risk of death in both patient groups 2.7-fold (1.22\u20135.83) for COVID-19, and 3.09-fold (1.11\u20137.38) for Influenza). The association with death remained significant upon adjustment to age and clinical parameters in COVID-19 but not in influenza infection. Secondary bacterial infection is a notable complication associated with worse outcomes in COVID-19 than influenza patients. Careful surveillance and prompt antibiotic treatment may benefit selected patients.<\/jats:p>","DOI":"10.1038\/s41598-021-92220-0","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T10:03:04Z","timestamp":1623837784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":196,"title":["Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Noa","family":"Shafran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Shafran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Ben-Zvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Sofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Sheena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Shlomai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella H.","family":"Sklan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"92220_CR1","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","volume":"8","author":"DE Morris","year":"2017","unstructured":"Morris, D. E., Cleary, D. W. & Clarke, S. C. Secondary bacterial infections associated with influenza pandemics. Front. Microbiol. 8, 1041\u20131041. https:\/\/doi.org\/10.3389\/fmicb.2017.01041 (2017).","journal-title":"Front. Microbiol."},{"key":"92220_CR2","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1086\/591708","volume":"198","author":"DM Morens","year":"2008","unstructured":"Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962\u2013970. https:\/\/doi.org\/10.1086\/591708 (2008).","journal-title":"J. Infect. Dis."},{"key":"92220_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrmicro3231","volume":"12","author":"JA McCullers","year":"2014","unstructured":"McCullers, J. A. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat. Rev. Microbiol. 12, 252\u2013262. https:\/\/doi.org\/10.1038\/nrmicro3231 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"92220_CR4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.4049\/jimmunol.1301152","volume":"191","author":"DW Metzger","year":"2013","unstructured":"Metzger, D. W. & Sun, K. Immune dysfunction and bacterial coinfections following influenza. J. Immunol. 191, 2047\u20132052. https:\/\/doi.org\/10.4049\/jimmunol.1301152 (2013).","journal-title":"J. Immunol."},{"key":"92220_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury, L., Lim, B., Baskaran, V. & Lim, W. S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J. Infect. 81, 266\u2013275. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.046 (2020).","journal-title":"J. Infect."},{"key":"92220_CR6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson, T. M. et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin. Infect. Dis. 71, 2459\u20132468. https:\/\/doi.org\/10.1093\/cid\/ciaa530 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"92220_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.micinf.2020.05.016","volume":"22","author":"S Zayet","year":"2020","unstructured":"Zayet, S. et al. Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster. Microbes Infect 22, 481\u2013488. https:\/\/doi.org\/10.1016\/j.micinf.2020.05.016 (2020).","journal-title":"Microbes Infect"},{"key":"92220_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30527-0","author":"L Piroth","year":"2020","unstructured":"Piroth, L. et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med https:\/\/doi.org\/10.1016\/S2213-2600(20)30527-0 (2020).","journal-title":"Lancet Respir Med"},{"key":"92220_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02068-16","author":"ME Mulcahy","year":"2016","unstructured":"Mulcahy, M. E. & McLoughlin, R. M. Staphylococcus aureus and influenza a virus: partners in coinfection. MBio https:\/\/doi.org\/10.1128\/mBio.02068-16 (2016).","journal-title":"MBio"},{"key":"92220_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2012.04.009","volume":"65","author":"C Cill\u00f3niz","year":"2012","unstructured":"Cill\u00f3niz, C. et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J. Infect. 65, 223\u2013230. https:\/\/doi.org\/10.1016\/j.jinf.2012.04.009 (2012).","journal-title":"J. Infect."},{"key":"92220_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00117","author":"B Villeret","year":"2020","unstructured":"Villeret, B. et al. Influenza a virus pre-infection exacerbates Pseudomonas aeruginosa-mediated lung damage through increased MMP-9 expression, decreased elafin production and tissue resilience. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00117 (2020).","journal-title":"Front. Immunol."},{"key":"92220_CR12","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","volume":"49","author":"ST Micek","year":"2005","unstructured":"Micek, S. T. et al. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob. Agents Chemother. 49, 1306\u20131311. https:\/\/doi.org\/10.1128\/AAC.49.4.1306-1311.2005 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"92220_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242533","volume":"15","author":"D Yu","year":"2020","unstructured":"Yu, D. et al. Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19. PLoS ONE 15, e0242533. https:\/\/doi.org\/10.1371\/journal.pone.0242533 (2020).","journal-title":"PLoS ONE"},{"key":"92220_CR14","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S0163-4453(09)60003-7","volume":"59","author":"N Woodford","year":"2009","unstructured":"Woodford, N. & Livermore, D. M. Infections caused by Gram-positive bacteria: a review of the global challenge. J. Infect. 59, S4\u2013S16. https:\/\/doi.org\/10.1016\/S0163-4453(09)60003-7 (2009).","journal-title":"J. Infect."},{"key":"92220_CR15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.amjmed.2006.03.012","volume":"119","author":"LB Rice","year":"2006","unstructured":"Rice, L. B. Antimicrobial resistance in gram-positive bacteria. Am. J. Med. 119, S11-19. https:\/\/doi.org\/10.1016\/j.amjmed.2006.03.012 (2006).","journal-title":"Am. J. Med."},{"key":"92220_CR16","unstructured":"Clinical Microbiology Procedures Handbook. 4 edn, (Wiley, 2016)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92220-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92220-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:54:24Z","timestamp":1670061264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92220-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92220"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92220-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}}],"article-number":"12703"}}